SCHEMBL6567262

SCHEMBL6567262

O=C(Nc1cc(Cl)c(O)c(Cl)c1)NC1Cc2ccccc2C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
MALT1 Q9UDY8 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALDH1A1 P00352 1/20 0.48
RAB9A P51151 4/20 0.46
NPC1 O15118 3/20 0.46
GRM7 Q14831 3/20 0.46
DHODH Q02127 1/20 0.46
EPHX2 P34913 3/20 0.45
TSHR P16473 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HTT P42858 1/20 0.45
EPHX1 P07099 2/20 0.44
LMNA P02545 2/20 0.44
PYGL P06737 1/20 0.43
MAPK13 O15264 1/20 0.43
MAPK12 P53778 1/20 0.43
MAPK11 Q15759 1/20 0.43
MAPK14 Q16539 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6650074 0.84 KMT2A (0.47) MEN1KMT2AALDH1A1RAB9ANPC1
SCHEMBL10361254 0.80 EPHX2 (0.65) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL6568610 0.79 RAB9A (0.63) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL4347065 0.78 RAB9A (0.66) MEN1KMT2AALDH1A1RAB9ANPC1
SCHEMBL6568591 0.78 TAS1R3 (0.61) MEN1KMT2AALDH1A1NPC1EPHX2
SCHEMBL6567565 0.75 CNR1 (0.71) DHODHEPHX2SMN1; SMN2LMNA
SCHEMBL4342381 0.75 KMT2A (0.68) MEN1KMT2AKDM4ERAB9ANPC1
SCHEMBL6567241 0.74 EPHX1 (0.59) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL21568131 0.71 KMT2A (0.58) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL22803295 0.70 EPHX1 (0.57) MEN1KMT2AKDM4ERAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed